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Abstract.  A monoclonal antibody (CG1) which recog- 
nizes tropomyosin isoforms 1 and 3 of chicken embryo 
fibroblasts was used to detect what is a motility- 
dependent change in the availability of the antigenic 
determinant in tropomyosin molecules along microfila- 
ments. Immunofluorescence microscopy with this anti- 
body revealed a heterogenous staining pattern among 
chicken embryo fibroblasts cells such that a population 
(17%) of cells showed only background staining.  Stress 
fibers in about half the population of the cells stained 
weakly with this antibody, while the stress fibers in 
another population of cells (35%) showed very strong 
staining. After glycerination or cytochalasin B treat- 
ment, all of the cells became positive in reaction to 
CG1 antibody, suggesting that the antigenic deter- 
minant was present in every cell. On the other hand, 
all of the cells after brief nonionic detergent treatment 
became negative to CG1  antibody. The CG1  staining 
pattern was not significantly changed in cells at differ- 
ent stages after release from colcemid blockage, nor 
was a brief treatment of cells with buffer containing 
2 M urea, mild trypsin, chymotrypsin, or V.8 protease 
effective in changing the reactivity. However, most of 
the cells with a morphology typical of movement, and 
all of the contracted, glycerinated cells were strongly 
positive to CG1 antibody. These results suggest that 
the unmasking of the CG1 determinant may be 
motility-dependent. Immunoblot analysis showed that 
forced modification on the cysteine residue of 
tropomyosin molecules, caused either by performic 
acid oxidation or by disulfide cross-linking with the 
chemical 5,5'-dithiobis (2-nitrobenzoate), results in 
drastic changes in the reactivity of the different iso- 
forms to CG1 antibody. These results indicate that the 
cysteine residue is involved in the CG1 determinant. 
The motility-dependent unmasking of this determinant 
may suggest an important role for nonmuscle tropo- 
myosin in regulating cell motility. 
T  ROPOMYOSIN is  a  dimeric coiled-coil  protein  that 
binds along the length of actin filaments. It is asso- 
ciated with the thin filaments of muscle cells and the 
microfilaments of  nonmuscle cells (5, 28, 33). We have previ- 
ously shown that chicken embryo fibroblasts  (CEF)  t con- 
tain at least five isoforms of tropomyosin (a, b, I, 2, and 3), 
identified  as  such  by  their different apparent  molecular 
masses after separation by SDS-PAGE, but similar biochem- 
ical properties,  such as resistance  to heat and organic sol- 
vents, the ability to bind to F-actin filaments, and the lack 
of proline and tryptophan  (25, 26). It is not known whether 
the  different  isoforms  have  different  localizations  and/or 
functions within CEF cells. However, such a situation is sug- 
gested by the fact that transformation of CEF cells by Rous 
sarcoma virus results in an altered pattern of expression of 
tropomyosin isoforms (25). 
Monoclonal antibodies have shown great promise as a tool 
for the study of tropomyosin isoforms.  Many monoclonals 
have been developed against CEF tropomyosins (23), one of 
1.  Abbreviations  used in  this paper:  CEE  chicken  embryo  fibroblasts; 
DTNB, 5.5'-dithiobis (2-nitrobenzoate). 
which has been shown by immunoblotting to react only with 
CEF tropomyosin isoforms  1 and 3.  This antibody, called 
CG1, displays an interesting and unusual staining pattern. A 
population  of CEF  cells  (~17%)  show only background 
staining. In the present study, we have shown that nonstain- 
ing cells can be experimentally induced to stain positively ei- 
ther by cytochalasin  B treatment to disrupt microfilament 
bundles, or by glycerol extraction. This result indicates that 
antigens recognized by CG1 antibody do exist in every cell. 
The availability of the CG1 antigenic determinant correlates 
well with the motile morphology.  Furthermore, we have 
shown that the cysteine residue of tropomyosin is involved in 
forming the antigenic determinant. 
Materials and Methods 
Cell Culture 
Primary CEF cell cultures were prepared by dissection and trypsin digestion 
of the skin of 10-d-old chick embryos as described previously (26). Cells 
were maintained in DME containing 10% FCS and incubated at 37"C in a 
humidified chamber with 5% CO2 and 95% air. Cells were used after the 
second, third,  and fourth passagings. 
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The preparation and characterization of anti-tropomyosin monoclonal anti- 
bodies CG1, CG[36, and CG3 were reported previously (23). The antibody 
CG1 recognizes isoforms 1 and 3 of CEF tropomyosin, the antibody CG3 
reacts with all isoforms (a, b,  1, 2, and 3), and the antibody CG[36 reacts 
with isoforms a, b, 1 and 2. Methods for preparing and characterizing rabbit 
antiserum against chicken gizzard tropomyosin were described in a previous 
report (32). This antiserum recognizes all isoforms of CEF tropomyosin. 
Indirect Immunofluorescence 
For immunofluorescence microscopy, cells were grown on 12 mm round 
glass coverslips to various densities (from 1 d after plating to confluency) 
before use. The standard procedure for indirect single-label or double-label 
immunofluorescence  was performed as described previously (22), including 
3.7 % formaldehyde fixation and cold acetone permeabilization. 
Several variations of this standard procedure were also performed. (a) 
Urea, chymotrypsin, trypsin, and V.8 treatment: after acetone extraction, 
cells were exposed to either 2 M urea or 20 ~g/mi protease in PBS (137 mM 
NaCl, 27 mM KCI, 1.5 mM KH2 PO4,  8 mM Na2HPO4, pH 7.3) for 30 s 
followed by washes in PBS and application of the primary antibodies (9). 
(b) Nonionic detergent extraction: ceils were extracted for 2 min in various 
concentrations (0.05, 0.1, 0.2, and 0.5%) of Triton X-100 or Nonidct P-40 
in Tris buffer (10 mM TrisCl, pH 7.5,  150 mM NaCI,  1 mM MgCI2) fol- 
lowed by a PBS rinse and then the standard fixation procedure. The deter- 
gent treatment was also performed after formaldehyde fixation, rather than 
before. (c) Colcemid treatment: cells grown on glass coverslips were treated 
with a low dose of coleamid (0.06  #g/nil) for 12 h. At various periods of 
time (15 min, 3, 13, and 18 h) after removal of the coleamid, coverslips were 
fixed and stained by the standard procedure. (d) Cytochalasin B treatment: 
cells grown on glass coverslips were treated with 10 ~g/ml of cytochalasin 
B. After 30 rnin the cells arborized, and then the medium was replaced with 
fresh medium. At 0,  10, and 25 min after the reversal, cells were fixed and 
stained by the standard procedure. (e) Glycerol-extracted cell models: the 
cell models used for inducing cell contraction were prepared exactly as de- 
scribed by Kreis and Birchmeier (15, 16). Briefly, cells grown on glass cover- 
slips were lysed with buffer containing 50% glycerol, 50 mM KCI, 5 mM 
EDTA, 10 mM Tris, pH 7.5, at 4"C for 2 h and then rinsed in contraction 
buffer (30 mM KC1, 5 mM MgCI2,  10 mM CaCI2,  and 10 mM Tris, pH 
7.5).  These cells were then induced to contract by the addition of ATP and 
MgCI2 in contraction buffer,  at a final concentration of 0.2 mM each. At 
various periods of time (2, 10, and 20 min), the contracted cells were fixed 
and double-labeled by the standard procedure with CGI monoclonal anti- 
body and rabbit anti-tropomyosin antiserum.  In another variation,  two 
Table L Populations of Control and Treated CEF Cells 
Stained with CG1 Monoclonai Antibody  for 
Immunofluorescence Microscopy 
Degree of CGI  staining 
Total number of 
Treatment  cells scored  Negative  Weak  Strong 
%  %  % 
Control  853  16.8  48.7  34.6 
Confluent  500  94.4  -  5.6 
Spreading*  181  4.4  63  32.6 
Cytochalasin  67  0  0  100 
Glycerol  70  0  0  100 
Contractedr  100  0  0  100 
Triton X-100  45  100  0  0 
Trypsin  183  14.8  47.5  37.7 
Chymotrypsin  177  15.8  49.7  34.5 
V.8 protease  179  12.8  51.9  35.2 
Urea  165  16.4  52.1  31.5 
Control and treated CEF cells were stained with CGI antibody for indirect im- 
munofluorescence microscopy. The cells were then scored for intensity of CG 1 
staining. 
* Cells were passaged 2 h before fixation and processing for immunofluores- 
cence microscopy. 
Cells were fixed  10 rain after addition of 0.2 mM Mg-ATP to induce con- 
traction. 
100-mm dishes of  CEF cells at confluence were extracted with 2 ml glycerol 
extraction buffer each. The extract was collected and dialyzed against con- 
traction buffer,  and then glyceroi-extrac~d models of cells grown on glass 
coverslips were incubated in the dialyzed extract for 30 min at room temper- 
ature. Finally,  the cells were fixed and stained for immunofluorescence ac- 
cording to the standard procedure described previously. The stained cells 
were observed and photographed using a Zeiss epifluorescence  photomicro- 
scope III with a Zeiss 63 x  oil-phase 3 lens as described previously by Blose 
(3). 
Performic Acid Oxidation and Protein Immunoblotting 
The CEF tropomyosin isoforms were prepared as described previously (25). 
The individual isoforms were further purified by electroelution of  the appro- 
priate gel bands from preparative SDS-polyacrylamide gels (23). After the 
removal of SDS by 80% cold acetone, the individual isoforms were allowed 
to renature and were used for performic acid oxidation and protein immuno- 
blotting. 
Performic acid oxidation of the individual isoforms was carded out ac- 
cording to Hirs (14). Briefly, the lyophilized tropomyosin isoforms were dis- 
solved in 0.2 ml performic acid reagent containiog 1 vol of 30% hydrogen 
peroxide and 9 vol of 88 % formic acid. The mixture was left in an ice bath 
for 2 h, and then the excess reagent was removed by repeated lyophilizntion. 
Protein immunoblotting was performed as described by Towbin et al. 
(35).  The individual isoforms and their oxidized counterparts were first 
separated on 12.5%  SDS-PAGE (23) and then electrophoretically trans- 
ferred to strips of nitrocellulose paper. One blot was stained with Amido 
black to reveal proteins, and a replicate blot was immunoreacted with CG1 
antibody as described previously (23). 
Tropomyosin lsoform Dimer Formation 
The chemical 5.5~dithiobis (2-nitrobenzoate), or DTNB,  was used to form 
intramolecular  cross-links  between  opposing  cysteine  residues  of  the 
purified tropomyosins as described previously (25). Briefly, the tropomyo- 
sin (0.2-0.5 mg/ml) was reacted with 10 mM DTNB for 30 min at room tem- 
perature, and then the samples were sohbilized in SDS-gel sample buffer 
without reducing agent dithiothreitol (DTT),  and run on a  12.5%  SDS- 
PAGE. To identify which isoforms formed dimers, the gel track was cut out 
and placed on top of a  new SDS-polyacrylamide slab gel.  This second 
dimension was run under reducing conditions by overlaying the gel track 
with sample buffer containing 100 mM DTT and 1% agarose. 
Results 
The  monoclonal antibody CG1  recognizes a  determinant 
present in CEF tropomyosin isoforms 1 and 3, but not iso- 
form 2 (23). Immunofluorescence  microscopy with this anti- 
body revealed stress fiber staining only on a subpopulation 
of CEF cells (Table I and Fig.  10 in reference 23). Scoring 
the cells by fluorescent intensity, we found that •17  % of the 
cells showed no staining, another 35 % showed strong stain- 
ing, and about half the population of the cells showed weak 
staining (control in Table I). This mixed staining pattern was 
not changed at a 100-fold higher concentration of CG1 anti- 
body. An identical result was also obtained when the stan- 
dard fixation procedure was replaced by cold methanol (data 
not shown). 
We have noted that those cells with strong staining fre- 
quently possess an identifiable leading lamella and a retrac- 
tion tail, suggesting that they were actively moving immedi- 
ately before they were fixed (1). Spindle-shaped cells and 
ameboid-shaped cells with pseudopod-like extensions also 
tend to have a much larger strong-staining population than 
do cells that are not in any of these categories (Table 1I). 
These three classes of cells (wedge-shaped, spindle-shaped, 
and ameboid-like) have been identified as actively motile by 
Herman et al. (13), using time-lapse videotaping. Thus, our 
observations suggest that the positive-staining state of the 
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Degree of CGI  staining 
Total number of 
Cell shape*  Movement*  cells scored  Negative  Weak  Strong 
%  %  % 
Wedge-shaped,  +  194  6.2  42.3  51.5 
with leading lamella  membrane ruffling 
and retraction tail 
Spindle-shaped  +  +  +  102  2  29.4  68.6 
translocating 
(.5-3.5 Ixm/min) 
Ameboid-like  + + +  102  4.9  24.5 
translocating 
(.5-3.5 itm/min) 
Others  Not characterized  455  27.3  61.1 




CEF cells were stained with CGI for indirect immunofluorescence microscopy. The cells were then scored for degree of staining. 
* These cell shape classifications and the information on degree and nature of cell motility were taken directly from Herman et al.,  1981 (13). 
CG1 determinant may be related to cell motility. This idea 
is also supported by the CG1 staining pattern displayed by 
cells that are spreading after replating, and by cells that have 
reached confluence. As can be seen from the data in Table 
I, a smaller proportion of spreading cells do not stain with 
CG1, as would be expected of cells that are assumed to be 
in  motion.  On  the  other  hand,  cells  that  have  reached 
confluence and are being held in check by contact inhibition 
show a  much larger population of negative cells: 94%  as 
compared with 17 % in the control group. Therefore, the avail- 
ability of the CG1 determinant may be motility-dependent. 
At least two possible explanations could account for the 
heterogenous staining of CEF cells by CG1 antibody. First, 
the unstained cells may contain no isoforms 1 and 3. This 
might be due to either the cell cycle-dependent expression 
of these isoforms or the contamination of our CEF prepara- 
tions by other cell types. The second possible explanation is 
that in unstained cells, the CG1 determinant is inaccessible 
due either to the presence of masking proteins or to the 
specific conformation of tropomyosin molecules on the actin 
microfilaments. To distinguish between these possibilities, 
we  have  examined  various  preparative  conditions  which 
might perturb the organization of the microfilaments or un- 
mask the determinant. 
When cells were treated with cytochalasin B,  which is 
known to disrupt microfilament bundles (10), CG1 antibody 
stained all cells (Fig.  1 B, Table I). This suggested that all 
cells in our preparation contained the antigens recognized by 
CG1  antibody. After the drug was washed away, the cells 
gradually reverted to the normal heterogenous CG1 staining 
pattern, and in addition regained their normal morphology 
(Fig.  1 D).  In another attempt to determine whether CEF 
cells contain only certain isoforms of non-muscle tropomyo- 
sin, we labeled single cells with [35S]methionine and then 
ran two-dimensional gels. In each of five cases, the cell con- 
tained all tropomyosin isoforms (data not shown). 
Glycerol-extracted cell models (16) and cells contracted af- 
ter the addition of Mg  ++ and ATP also showed uniformly 
strong  staining by CG1  antibody (Figs.  2  and 3).  These 
results further argued against the possibility that some cells 
in our preparations contained no antigens recognized by CG1 
antibody, and suggested that glycerol extraction may unmask 
the antigenic determinant either by removing masking pro- 
teins from the tropomyosin molecule or by inducing a local 
conformational change in tropomyosin. When the glycerol 
extract of CEF cells was dialyzed against contraction buffer 
and then added back to glycerol-extracted cell models, the 
heterogcnous CGI  staining pattern did not reappear.  The 
same results were also obtained with the add back experi- 
ment using a 10-fold higher concentration of  glycerol extract. 
Therefore, this result does not support the possibility that 
glycerol  extraction  reveals  the  determinant by  removing 
masking proteins. 
In an attempt to rule out the possibility that the heter- 
ogenous staining by CG1  antibody was due to interphase 
cells at different stages of the cell cycle, cells partially syn- 
chronized by  colcemid blockade were processed  for im- 
munofluorescence microscopy. Cells stained with CG1 anti- 
body at different time intervals after the removal of colcemid 
showed no significant difference from control cells in the 
proportions of stained and unstained cells (data not shown). 
These results suggest that the heterogenous staining pattern 
exhibited by CG1 antibody does not result from the presence 
of CEF cells at different stages  in the cell cycle. 
The next challenge was to distinguish between the pres- 
ence of a masking protein and a conformational change in 
the tropomyosin molecule. In an attempt to extract any mask- 
ing protein, we treated the cells briefly with 2 M urea or mild 
trypsin, chymotrypsin, or V.8  protease solution and then 
stained them for immunofluorescence microscopy, accord- 
ing to the method of Franke (9). As can be seen in Table I, 
the treatments with 2 M urea or trypsin appeared to damage 
the cells somewhat, but the CG1 staining pattern was not al- 
tered in either case. Similar results were obtained with the 
other proteases. Again, these results do not support the pos- 
sibility that a removable masking protein prevents the deter- 
minant from recognition. 
Nonionic detergent extraction of the cells before staining 
for immunofluorescence changed the standard CG1 staining 
pattern greatly but did not affect staining by other monoclo- 
hal and polyclonal antibodies against tropomyosin. After a 
brief extraction with various concentrations of Triton X-100, 
Hegmann et al.  Nonmuscle Tropomyosin  lsoforms and Motility  387 Figure 1. Indirect immunofluorescence of CEF cells at either 30 min after start of a cytochalasin B treatment (A and B), or 25 min after 
the reversal of cytochalasin B treatment (C and D). Cells were stained with monoclonal antibody CG1. (A and C) phase-contrast micro- 
graphs; (B and D) fluorescent micrographs. Bar, 10 Ixm. 
all of the CEF cells showed no CG1 staining except for a faint 
nuclear fluorescence (data not shown). The possibility that 
Triton extraction may remove tropomyosin has also been ex- 
mined by two-dimensional gel analysis. While 20--40%  of 
tropomyosin was  extracted with  0.5%  Triton X-100 from 
CEF cells, no significant amounts of tropomyosin, including 
isoform 3, were extracted with 0.05 % Triton X-100. Cells ex- 
tracted by  glycerol before Triton treatment  and  cells  ex- 
tracted with KTG solution (0.05%  Triton X-100 and  30% 
glycerol in 0.1  M  Pipes,  pH 6.9,  5  mM  MgC12, 0.2  mM 
EGTA) do not show the loss of CG1  staining exhibited by 
cells extracted in Triton alone.  These results are not what 
would be expected if the CG1  antigenic determinant were 
masked by some other protein; detergent extraction of a pro- 
tein obstructing the antibody-binding site  should enhance 
staining, not block it. Also, the effect must be limited to the 
region of the CG1 determinant, since polyclonal antibodies, 
and  even other monoclonal antibodies,  show  very bright 
stress fiber staining after Triton extraction (data not shown). 
For these reasons, the lack of CG1  staining after Triton ex- 
traction argues against the possibility of a masking protein 
but indirectly supports a  model in  which the CG1  deter- 
minant exists in at least two conformational states,  one of 
which is recognized by CG1  and one of which is not. This 
model provides a  mechanism by which nonmuscle tropo- 
myosin might play a regulatory role in the actin-myosin inter- 
action. However, the direct evidence to support this model 
remains to be obtained. 
To further investigate the CG1 antigenic determinant, we 
purified individual  tropomyosin isoforms and  carried out 
performic acid oxidation to force a change in conformation 
around the cysteine and methionine residues in the polypep- 
tide. Then we used protein immunoblots to compare the re- 
activity of CG1 antibody with these proteins before and after 
oxidation. Fig. 4 shows the results of such blots. After oxida- 
tion, all three isoforms showed substantial changes in their 
mobilities  in  SDS-PAGE  (Fig.  4  A).  Before  oxidation, 
tropomyosin isoform 1 was weakly recognized by the CG1 
antibody.  Surprisingly,  its  oxidized form showed a  much 
stronger reactivity with the same antibody (Fig. 4 B). Con- 
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orescence of  control (A and B) 
and  glycerinated (C and  D) 
CEF cells stained with mono- 
clonal antibody CG1. (A and 
C)  phase-contrast  micro- 
graphs; (B and D) fluorescent 
micrographs. Bar, 10 am. 
sistent with our previous report (23), neither lsolorm 2 nor 
its oxidized form were recognized by the CG1 antibody (Fig. 
4  B).  By contrast, tropomyosin isoform 3 was recognized 
very strongly by the CGI antibody before oxidation, but the 
performic acid oxidation destroyed its antigenicity (Fig. 4 
B). These results suggest that the antigenic determinant rec- 
ognized by the CG1 antibody may involve the cysteine or me- 
thionine residues. 
DTNB is a chemical that Iorms interchain disulfide cross- 
links between adjacent cysteine molecules. It has been used 
by Lehrer and colleagues (19, 20) to demonstrate the exis- 
tence of two conformational states of the region around the 
Cys-190 residue of skeletal muscle tropomyosin. In the pres- 
ent study, we used DTNB in an experiment similar to the per- 
formic  acid  oxidation  described  above,  except  that  the 
change in cysteine residue induced by DTNB is much more 
Hegmann eta|. tVonmuscle Tropomyosin lsoforms and Motih~v  389 Figure 3.  Indirect double-label immunofluorescence of contracted,  glycerinated CEF cells stained with both monoclonal antibody CGI 
and rabbit polyclonal antiserum against tropomyosin. (A-L) Glycerinated cells undergoing contraction at 0, 2, 10, and 20 min, respectively, 
after the addition of Mg-ATP. (A, D, G, and J) Phase-contrast micrographs;  (B, C, E, F, H, L K, and L) fluorescent micrographs.  (B, 
E, H, and K) Ceils reacted with CG1 antibody and detected with tetramethyl rhodamine isothiocyanate-conjugated goat anti-mouse IgG. 
Note that all the cells stain positively. (C, F, I, and L) Cells in the same fields seen in B, E, H, and K, respectively, reacted with rabbit 
anti-tropomyosin  and detected with FITC-conjugated goat anti-rabbit  IgG. Bar,  10 ~tm. 
specific than that induced by performic acid oxidation.  As 
can be seen from the blot stained with Amido black in Fig. 
5, CEF tropomyosin after DTNB treatment forms a heterodi- 
mer of isoforms a and c, and homodimers of isoforms 1 and 
3.  The  tropomyosin  isoforms  in  this  oxidized  gel  were 
identified by two-dimensional SDS-PAGE with the oxidized 
condition as the first dimension and the reduced condition 
as the second condition  (25). 
Immunoblot analysis of purified tropomyosin treated with 
DTNB showed that CG1 recognized monomers of isoforms 
1 and 3, but did not recognize homodimers of dimers involv- 
ing these isoforms (Fig.  5).  Another monoclonal antibody, 
CGI36, reacts with monomers of isoforms a, b,  1 and 2, as 
well as any dimers that contain one or more of these isoforms 
(a-c and 1-1). Thus, the change in cysteine residue induced 
by DTNB crosslinking prevented CG1  staining. 
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clonal  antibody  CGI  binding  to  purified  CEF 
tropomyosin isoforms and  their respective oxi- 
dized products obtained by performic acid oxida- 
tion. Purified tropomyosin isoforms (TM-1, TM-2, 
and TM-3) and their oxidized products were sepa- 
rated on SDS-PAGE. After electrophoresis, pro- 
teins were transferred to nitrocellulose paper and 
either stained with Amido black (A) or immuno- 
blotted with monoclonal antibody CG1 (B). The 
reactivity of CGI  antibody to TM-I greatly  in- 
creases after oxidation of TM-1. On the other hand, 
the loss of reactivity is evident for the oxidized 
form of TM-3. 
Discussion 
The heterogeneity of the CG1  staining pattern does not ap- 
pear to be artifactual. The pattern is not changed at different 
concentrations of antibody, nor is it the result of a mixture 
of cell types, since our CEF cell cultures show very little 
contanu'nation by other cell types (26). Second antibodies la- 
beled with tetramethyl rhodamine isothiocyanate or FITC 
both allow visualization of  the heterogenous staining pattern. 
Since all cells are strongly positive to CG1 staining after 
glycerination or cytochalasin B treatment, it is likely that 
the CG1  determinant (or tropomyosin isoforms 1 and 3) is 
present in all cells.  From two-dimensional gel analysis of 
[35S]methionine-labeled single cells, we have noted that all 
tropomyosin isoforms could be  detected in  the  five cells 
tested (data not shown).  These results further support the 
idea that every cell contains the antigenic determinant recog- 
nized by CG1 antibody, but that this determinant is not acces- 
sible for antibody binding in some populations of cells. 
Whether this heterogenous staining pattern reflects func- 
tional differences of tropomyosins or microfilaments is not 
known. Based on the results with cells partially synchronized 
with colcemid, this selective masking seems independent of 
cell cycle. There are many possible explanations for the un- 
masking effect  of glycerol and cytochalasin B, such as the ex- 
traction of a masking protein or the induction of a conforma- 
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Figure 6.  Schematic model for the two conformational states of 
skeletal tropomyosin proposed by Lehrer and colleagues (2, 20). 
A stable chain-closed state and a somewhat less stable chain-open 
state have been detected in the region near the Cys-190  residue (indi- 
cated by SH) of native skeletal tropomyosin. The existence of this 
chain-open state gives considerable flexibility to skeletal tropomyo- 
sin, thereby conferring its regulatory role in muscle contraction. 
This chain-open, locally unfolded state can also explain the ability 
of 5,5'-dithiobis (2-nitrobenzoate) to form a disulfide cross-link be- 
tween the subunits of skeletal tropomyosin. 
Figure 5.  Protein immunoblot analysis of monoclonal antibodies 
CG1, CG[~6, and CG3 binding to CEF tropomyosin isoforms and 
the isoform dimers (1-1, 3-3, a-c) formed after DTNB treatment. 
CG1 recognizes TM-1 and TM-3 monomers. CGfl6 recognizes iso- 
forms a, b, 1, and 2 as well as dimers involving any of these iso- 
forms. Similarly, CG3 recognizes isoforms 1, 2, and 3 and also 
recognizes dimers involving any of these species. (x and y) Un- 
known proteins, detected by CG3 antibody. They may be the result 
of dimerization of any of the CEF tropomyosin isoforms with other 
contaminant proteins in our partially purified preparation.  They 
failed to be identified in our Coomassie Blue-stained two-dimen- 
sional SDS-polyacrylamide gel (25). 
tional change in a  masking protein or in the tropomyosin 
molecule itself. However, treatment with 2 M urea or mild 
trypsin, chymotrypsin, or V.8 protease, which in other cases 
has shown the ability to extract or loosen masking compo- 
nents (9), has failed to change the heterogenous staining pat- 
tern.  Nonionic detergent extraction of CEF cells prevents 
staining by CG1 but does not prevent staining by other anti- 
bodies specific to tropomyosin. Furthermore, the detergent 
at 0.05 % concentration does not extract the tropomyosin it- 
self, including isoform 3, as judged by two-dimensional gel 
analysis. The lack of CG1 staining after detergent extraction 
is much more easily explained by a change of conformation 
in the CG1 antigenic determinant than by the existence of a 
masking protein, since the extraction of a masking protein 
would not be expected to cause a decrease in staining inten- 
sity.  This  reasoning  is  supported by  the  observation that 
glycerol is  able to stabilize the tropomyosin in  some way 
which  prevents  the  loss  of CG1  staining  after  detergent 
treatment. 
The skeletal tropomyosin on thin filaments is believed to 
undergo a conformational change in response to a change in 
Ca  ++  concentration.  Through this  change,  tropomyosin is 
able to regulate interactions between actin and myosin, lead- 
ing to muscle contraction and relaxation (8, 18). Two confor- 
mational states (a stable chain-closed state and a chain-open 
state) have been detected in the region near the Cys-190 resi- 
due of native skeletal tropomyosin in solution (2, 19, 20). A 
schematic representation of these states is shown in Fig. 6. 
The existence of this  chain-open state gives  considerable 
flexibility  to  skeletal  tropomyosin,  making  possible  its 
regulatory role in muscle contraction (2, 20).  This chain- 
open, locally unfolded state can also explain the ability of 
5,5'-dithiobis  (2-nitrobenzoate),  an  interchain  disulfide 
cross-linker, to form disulfide cross-links between subunits 
of  both skeletal and cardiac tropomyosins by oxidation of op- 
posing cysteine residues (19). We have previously shown that 
CEF tropomyosin isoforms 1 and 3, but not 2,  are able to 
form cross-linked homodimers under the same conditions as 
striated tropomyosins form dimers, suggesting that these iso- 
forms have a region analogous to the Cys-190 region of skele- 
tal tropomyosin. Coincidently, the CG1 antibody recognizes 
isoforms 1 and 3, but not 2 (23). It is possible that the anti- 
genic determinant recognized by CG1 antibody is the region 
near Cys-190, and that this localized region on isoforms 1 and 
3 can exist in two different conformational states (chain-open 
and  chain-closed).  For  this  reason,  we  targeted  cysteine 
residues, and the presumed Cys-190 residue in particular, in 
our attempts to force changes in the tropomyosin molecule 
with performic acid oxidation and  DTNB treatment.  The 
results we have presented indicate that the reactivities of the 
CG1 antibody to its antigens can be artificially altered to be- 
come either stronger or weaker after performic acid oxida- 
tion of tropomyosin isoform 1 or 3, respectively. This sug- 
gests that the CG1  antibody may recognize a  determinant 
involving the cysteine residue. In addition, CG1  recognizes 
monomers  of isoforms  1  and  3  but  not  the  homodimers 
formed after  DTNB  treatment.  This  evidence,  combined 
with the fact that the majority of the morphologically-iden- 
tifiable motile cells stain strongly positive with this antibody, 
makes it reasonable to postulate that the determinant recog- 
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within the living cells. Whether this change is due to confor- 
mational  change remains  to be determined. 
Is the antigenic determinant recognized by CG1 antibody 
one of the important regions for tropomyosin  function? To 
test  this  possibility,  we  have  started  experiments  with 
microinjection of this antibody into living cells. Preliminary 
results show that cells injected with intact antibody change 
their morphology and collapse into tight balls.  When Fab 
fragments of CG1 antibody are used, many of the injected 
cells retain their spread morphology but cease their intracel- 
lular granule movement (11). A detailed report will be pub- 
lished elsewhere. 
We and other investigators have previously shown (a) that 
nonmuscle cells so far examined express multiple isoforms 
of tropomyosin;  (b)  that major tropomyosin isoforms are 
greatly  reduced and minor isoforms are increased  in many 
different types of transformed cells (12,  17, 21, 25, 27, 30); 
and (c) that minor isoforms with smaller apparent molecular 
mass appear to have a weaker actin-binding ability than ma- 
jor isoforms with higher apparent molecular mass (6, 7, 25, 
31). In addition, we have used isoform-specific antibodies to 
demonstrate  in  some  preliminary  experiments  that  CEF 
tropomyosin isoform 3 has a different intracellular localiza- 
tion than other major isoforms (24). Together, these results 
suggest that the expression of various amounts of the differ- 
ent nonmuscle tropomyosin isoforms and the differential dis- 
tribution of these isoforms in localized regions  of the cell 
may be a critical component in the regulation of motility and 
shape  maintenance  by  nonmuscle  cells.  The  molecular 
mechanism by which nonmuscle tropomyosins regulate the 
actin-myosin interaction is still an open question. In the pres- 
ent study, a motility-dependent  change  in the availability of 
a determinant of nonmuscle tropomyosin has been detected 
by a monoclonal antibody.  This,  together  with the recent 
reports (4, 29, 34) that both smooth muscle and nonmuscle 
cells contain  a Ca++/calmodulin-binding  and actin-binding 
protein (caldesmon), may suggest a type of regulation analo- 
gous to the tropomyosin-troponin  complex in striated mus- 
cles, although some differences between caldesmon and the 
troponin complex have been noted (4). 
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